Similar articles for PMID: 22850601

Year	Number of Results
1998	1
1999	1
2002	1
2003	3
2004	1
2005	1
2007	3
2008	3
2009	4
2010	7
2011	4
2012	8
2013	5
2014	11
2015	13
2016	3
2017	1
2018	2
2019	3
2020	3
2021	1
2022	1
2023	2
2024	0

1

Predictive genetic testing for drug-induced liver injury: considerations of clinical utility.

Alfirevic A, Pirmohamed M. Alfirevic A, et al. Clin Pharmacol Ther. 2012 Sep;92(3):376-80. doi: 10.1038/clpt.2012.107. Epub 2012 Aug 1. Clin Pharmacol Ther. 2012. PMID: 22850601 Review.

2

Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.

Grove JI, Aithal GP. Grove JI, et al. Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):395-409. doi: 10.1517/17425255.2015.992414. Epub 2014 Dec 10. Expert Opin Drug Metab Toxicol. 2015. PMID: 25491399 Review.

3

Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.

Aithal GP. Aithal GP. Liver Int. 2015 Jul;35(7):1801-8. doi: 10.1111/liv.12836. Epub 2015 Apr 20. Liver Int. 2015. PMID: 25809692 Review.

4

Genetic Predisposition to Drug-Induced Liver Injury.

Stephens C, Andrade RJ. Stephens C, et al. Clin Liver Dis. 2020 Feb;24(1):11-23. doi: 10.1016/j.cld.2019.08.003. Epub 2019 Oct 31. Clin Liver Dis. 2020. PMID: 31753244 Review.

5

Genetic association studies in drug-induced liver injury.

Daly AK, Day CP. Daly AK, et al. Drug Metab Rev. 2012 Feb;44(1):116-26. doi: 10.3109/03602532.2011.605790. Epub 2011 Sep 14. Drug Metab Rev. 2012. PMID: 21913872 Review.

6

Genome-Wide Association Studies in Drug-Induced Liver Injury: Step Change in Understanding the Pathogenesis.

Aithal GP, Grove JI. Aithal GP, et al. Semin Liver Dis. 2015 Nov;35(4):421-31. doi: 10.1055/s-0035-1567829. Epub 2015 Dec 16. Semin Liver Dis. 2015. PMID: 26676816 Review.

7

Genetic basis of drug-induced liver injury: present and future.

Urban TJ, Daly AK, Aithal GP. Urban TJ, et al. Semin Liver Dis. 2014 May;34(2):123-33. doi: 10.1055/s-0034-1375954. Epub 2014 May 31. Semin Liver Dis. 2014. PMID: 24879978 Review.

8

Research advances in the association of drug-induced liver injury with polymorphisms in human leukocyte antigen.

Ma Q, Yang W, Wang L, Ma L, Jing Y, Wang J, Liu X. Ma Q, et al. Int Immunopharmacol. 2020 Apr;81:106037. doi: 10.1016/j.intimp.2019.106037. Epub 2019 Nov 26. Int Immunopharmacol. 2020. PMID: 31784402 Review.

9

Genetic risk factors in the development of idiosyncratic drug-induced liver injury.

Stephens C, Lucena MI, Andrade RJ. Stephens C, et al. Expert Opin Drug Metab Toxicol. 2021 Feb;17(2):153-169. doi: 10.1080/17425255.2021.1854726. Epub 2020 Dec 14. Expert Opin Drug Metab Toxicol. 2021. PMID: 33222552 Review.

10

Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.

Parham LR, Briley LP, Li L, Shen J, Newcombe PJ, King KS, Slater AJ, Dilthey A, Iqbal Z, McVean G, Cox CJ, Nelson MR, Spraggs CF. Parham LR, et al. Pharmacogenomics J. 2016 Apr;16(2):180-5. doi: 10.1038/tpj.2015.40. Epub 2015 May 19. Pharmacogenomics J. 2016. PMID: 25987243 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

66 results

Results by year